Tagged: cambridge
30 results
Elad Ferber
Elad Ferber is the CEO and co-founder of Synthpop, a healthcare AI company that uses multi-agent automation to handle the administrative work behind patient care - referrals, prior authorizations, eligibility checks, documentation, and claims. A former Israeli Air Force Talpiot cadet and systems engineer with a Stanford MBA, Ferber previously co-founded the remote patient monitoring startup Spry Health, which was acquired by ZOLL Itamar in 2021. Founded in 2023 with CTO Jan Jannink, Synthpop has raised $23 million to date and pitches its AI as a labor solution that compresses 40-minute back-office tasks into under a minute.
Flagship Pioneering
Flagship Pioneering is a Cambridge, Massachusetts life-sciences enterprise that invents, builds, and funds companies rather than merely investing in them. Founded in 1999 by Noubar Afeyan, the firm runs a systematic 'venture creation' engine - generating scientific hypotheses in-house, prototyping them in its own labs, and spinning validated concepts into independent operating companies in human health and sustainability. Its portfolio has produced more than 100 ventures, including Moderna, and it directs roughly $14 billion in capital.
Axiomatic AI
Axiomatic AI is a Cambridge, Massachusetts deep-tech company building AI that engineers can actually trust. It pairs frontier language models with formal mathematical and physics-based verification so that the reasoning behind a design decision can be checked, proven, and traced. Its first commercial focus is photonics and semiconductor engineering - fields where simulations are sophisticated but fragmented and a fabrication error is expensive. Founded in 2024 by a group of MIT and ICFO physicists and led by former White House quantum-policy lead Jake Taylor, the company raised an $18M seed in March 2026 to build what it calls the intelligence infrastructure for verified science and engineering.
basys.ai
basys.ai is a Cambridge, Massachusetts healthcare technology company that builds enterprise-grade, domain-specific AI for health plans and payers. Founded in 2022 by Harvard health data science alumni Amber Nigam and Jie Sun, the company automates prior authorization, utilization management, and payment integrity, turning a process that can take days into decisions rendered in minutes - with plain-language rationales and hyperlinks to the exact policy criteria and clinical notes behind each decision. The platform is designed to encode a payer's own coverage policies so it can compare them against a patient's longitudinal record without requiring integration marathons or sensitive data handoffs.
CL Global Academy
CL Global Academy is an independent international education company that runs academically rigorous, project-based short courses in the heart of Cambridge, UK. Founded in 2009 by Allen Hao and Katrina, it hosts residential programmes inside historic Cambridge colleges - taught by University of Cambridge-affiliated lecturers - covering fields from AI and data science to innovation and entrepreneurship. The Academy welcomes over 1,500 students a year and counts more than 24,000 alumni across 16 years, having grown into a multi-million-dollar business without institutional venture funding.
Datalign Advisory
Datalign Advisory is a Cambridge, Massachusetts fintech that uses an AI-enhanced platform to match everyday Americans with vetted, fiduciary Registered Investment Advisor (RIA) firms. Consumers answer a short questionnaire and get one personalized advisor match at no cost; advisory firms pay Datalign a referral fee for qualified introductions. Founded in 2022 out of the Link Ventures / Cogo Labs orbit, the company referred roughly $40 billion in assets to RIA firms in 2024 and raised $9M in total seed funding at a $75M post-money valuation.
Leo AI
Leo AI is a Cambridge, Massachusetts company building what it calls the world's first AI purpose-built for mechanical engineering. Its engineering design co-pilot, powered by a proprietary Large Mechanical Model (LMM) trained on millions of real-world products and engineering standards, turns text, sketches and specifications into production-ready 3D CAD models. Leo integrates with CAD and PDM systems to answer technical questions, source parts, run mechanical calculations and generate design concepts, and says it helps teams cut engineering time by up to 70%.
Pascal
Pascal is a Cambridge, Massachusetts climate-tech company commercializing solid refrigerants to replace the greenhouse-gas coolants that make air conditioners, heat pumps, and refrigerators bad for the climate. Spun out of Harvard in 2023, Pascal builds cooling systems around barocaloric materials - wax-like layered solids that absorb and release heat when squeezed and released - working at pressures low enough to run on today's mass-market HVAC hardware. The company raised an $8M seed round in 2024 and aims to eliminate refrigerant emissions while cutting cost and boosting efficiency.
Soofa
Soofa builds solar-powered, network-connected digital signs that turn ordinary street corners into two-way community bulletin boards. Spun out of the MIT Media Lab in 2014, the women-founded company started with a phone-charging park bench and grew into a network of zero-carbon kiosks that broadcast hyperlocal news, transit updates, and events while giving advertisers and cities measurable pedestrian data - smart, social, and sustainable street furniture for the modern city.
Jane Chen
Jane Chen is the founder and CEO of Letterly, an AI-assisted, human-in-the-loop writing platform that has helped more than 3,000 students across 30 states and seven countries write, revise, and publish their own work. A New York-born daughter of Chinese immigrants who returned from Shanghai unable to speak English, she studied history at Harvard, spent a decade on Wall Street as an investment banker and hedge fund analyst, then walked away from finance to rebuild how kids learn to write - starting with 30 students at a community center and growing into a seed-funded company with nearly 13,000 published student articles.
Joshua Wong
Joshua Wong is the co-founder and CEO of Hypotenuse AI, a Y Combinator-backed generative AI platform used by Fortune 500 ecommerce brands to write product descriptions, edit images, and manage product data at scale. A Cambridge computer scientist and former Amazon applied research scientist, he started coding at 11 and turned a side project for friends running online stores into a company serving over 500,000 users worldwide.
Jutta Friedrichs
Jutta Friedrichs is a German-born designer and co-founder of Soofa, the Cambridge, MA company that makes solar-powered digital signs for city sidewalks. Before Soofa she ran the MÜ furniture studio in Shanghai, co-founded Xindao's in-house design team, won two Red Dot Awards, an iF Design Award and an Elle Decoration Award, and earned a Masters at the Harvard Graduate School of Design. She mentors at the Harvard Innovation Lab and works at the seam of hardware, human-centered design, and the civic public realm.
Karl Ruping
Karl Ruping is the founder and CEO of Tiba Biotech, a Cambridge, Massachusetts company developing biodegradable nanoparticle delivery systems for RNA vaccines and therapeutics. He also runs incTANK Ventures, a seed fund spun out of MIT and Boston-area research labs, and sits at Harvard's Asia Center as an associate working on international patent policy. Lawyer, computational scientist, financier, and operator wrapped into one resume.
Allen Hao
Allen Hao is the founder and CEO of CL Global Academy, an international education company he co-founded in 2009 with Katrina Hao after the two met in Cambridge. From offices in the UK, Shanghai, and the US, the academy runs its 'OxCam Programmes' - short, project-based academic courses taught in Cambridge colleges by University-affiliated faculty. Hao has called himself an entrepreneur since age 16 and built the company without external funding into a profitable business serving over 1,500 students a year, with a claimed 24,000-plus alumni. Internally he goes by the title 'Chief Student-Centered Officer.' Born in Shanghai and splitting time between Cambridge and Madison, Wisconsin, he completed a Master's at the University of Cambridge from 2023 to 2025.
Alistair McLeay
Alistair McLeay is the Wellington-raised, Cambridge-trained machine learning engineer who co-founded Grw AI, a San Francisco startup building Taylor, an AI sales teammate that coaches and lifts entire sales teams. He shipped product to a million Xero customers, wrote a master's thesis training LLM agents through self-play, built two software companies, and raised Silicon Valley money after a now-legendary poker game. He serves as Co-Founder and Co-CEO.
Amber Nigam
Amber Nigam is the co-founder and CEO of basys.ai, a Harvard-born healthcare AI company teaching software to navigate one of medicine's most despised rituals: prior authorization. Trained on more than 10 million patient records and claims, basys.ai's engine encodes payer policy and automates up to 90% of authorization requests, aiming to give clinicians their time back and patients faster answers. A Harvard Health Data Science graduate, three-time patent inventor, and published researcher at venues like NeurIPS and ACL, Nigam came to Boston from Bareilly, India, after first building an ed-tech startup, kydots.ai. He has spoken at TEDx, Mayo Clinic, Harvard, and MIT, and has been named to multiple 40 Under 40 lists.
Emily Nieves
Emily Nieves is the co-founder and CEO of Delineate, a Cambridge, Massachusetts startup building AI agents that read the scientific literature the way a pharmacologist does - pulling numbers out of buried plots and patents to speed up drug development. A University of Georgia biological engineer turned MIT PhD researcher, she worked on computational modeling at Pfizer and AstraZeneca before deciding the bottleneck wasn't the models but the months it took to feed them. Delineate, part of Y Combinator's Winter 2025 batch, now works with top-10 pharma companies to turn months of systematic review into weeks.
Matt Pelc
Matt Pelc is the co-founder and CEO of Plane, the all-in-one people platform (formerly Pilot) that helps fast-growing startups pay and manage employees and contractors in 100+ countries. A Cambridge-trained computer scientist who got his start writing Ruby and building Slack bots, he went through Y Combinator's Winter 2017 batch and has spent the better part of a decade trying to make a worker's location irrelevant to whether a company will hire them.
Satayan Mahajan
Satayan Mahajan is the founding CEO of Datalign Advisory, a Cambridge, Massachusetts fintech that matches Americans with vetted fiduciary financial advisors using AI and human-centered design. An MIT alumnus and Media Lab pioneer, he spent two decades building motion-capture and gaming companies (Motus, iClub) before an eight-year run at Amazon as a GM and Head of Product. He returned to startup mode in 2024 when Cogo Labs founder Dave Blundin recruited him to lead Datalign, which has since referred more than $80 billion in assets across thousands of advisors.
Alastair Adam
Alastair Adam is the co-founder and Co-CEO of FlatWorld, the Boston-based publisher on a mission to bring US college textbook prices back down to earth. A Cambridge-trained lawyer who started in London M&A, he spent two decades advising the information and publishing world before buying the assets of the old Flat World Knowledge in 2016 and rebuilding it. Today FlatWorld's peer-reviewed, low-cost titles are used by faculty at well over 1,500 North American institutions. He also chairs the board of PLOS, the nonprofit open-science publisher.
HyperLight Corporation
HyperLight is a Cambridge, Massachusetts company that designs and manufactures photonic integrated circuits on thin-film lithium niobate (TFLN), a material prized for ultrafast, low-voltage electro-optic modulation. A 2018 spin-out from Marko Loncar's lab at Harvard, the company built what it describes as the industry's first high-volume, qualified 6-inch TFLN manufacturing line - now expanding to 8-inch - and packages it as a modular TFLN Chiplet platform. Its modulator chips target the bandwidth and power-efficiency demands of AI data centers, telecom optical networks and high-performance computing, enabling 1.6 Tbps-class links at CMOS-level drive voltages.
Andy Kidd
Andy Kidd is the chief executive officer of Tentarix Biotherapeutics, a San Diego company building conditionally active multispecific biologics for oncology and autoimmune disease through its Tentacles platform. A physician turned operator, he carries an unusual pairing of credentials - an M.D. from Oxford and a CFA - and spent over two decades crossing from the consulting room into the boardroom, from Boston Consulting Group to Baxter International to the helm of Nasdaq-listed Aptinyx, which he took public. He stepped into the Tentarix CEO seat in April 2024 to scale a science-heavy startup backed by partnerships with Gilead and AbbVie.
Andy Walker
Andy Walker is a chemical engineer turned biotech operator who co-founded GentiBio, a Cambridge-based company engineering regulatory T cells (EngTregs) to functionally cure autoimmune and autoinflammatory diseases. He started as the company's CTO, moved through President and COO, and became President and CEO in 2024. Before GentiBio he ran manufacturing for cell and protein therapeutics at Juno Therapeutics and led Jewel Biotherapeutics. He holds a PhD in chemical engineering from UC Berkeley and a BS from the University of Washington.
Cheri Ackerman Araromi
Cheri Ackerman Araromi is the cofounder and CEO of Concerto Biosciences, a Cambridge, Massachusetts biotech that reads the social lives of microbes the way a producer reads a band. Using kChip, a droplet screening platform she helped build during her postdoc at the Broad Institute, Concerto tests how thousands of microbial combinations interact and assembles the winning ensembles into products for skin health, agriculture, and beyond. A Hertz Fellow with a Berkeley PhD in chemical biology, she frames the future of medicine as building healthy ecosystems rather than killing bad cells with toxins.
James Hawkins
James Hawkins is the co-founder and co-CEO of PostHog, the open-source product analytics platform built for engineers. He pivoted five times inside Y Combinator's W20 batch before landing on PostHog, then turned a Hacker News launch and a single tweet into a developer cult following and a $1.4 billion valuation. A former marketing operator and self-described 'very bad developer,' Hawkins runs PostHog on radical transparency, tiny autonomous teams, and a refusal to be boring.
Kevin Xu
Kevin Xu is the Chairman and CEO of ClinChoice, a global full-service contract research organization (CRO) with more than 30 years of history, roughly 4,000 staff, and operations across 15+ countries. He arrived in the corner office from the investor's side of the table: for over 15 years he was a Managing Director at Goldman Sachs, where he built and ran the firm's Asia-Pacific Healthcare and Life Sciences investing practice, leading deals across biotech, pharma, medtech, CROs/CDMOs and digital health. Trained in neuroscience and clinical psychology before finance, he is an outspoken advocate for destigmatizing mental illness and an unlikely wake-surfer.
Meena Mallipeddi
Meena Mallipeddi is the co-founder and CEO of AmplifyMD, an EHR-integrated, multi-specialty virtual care platform and national physician network that helps hospitals close specialist coverage gaps. Raised in a family of doctors and trained as a Stanford honors grad, Cambridge Gates Scholar, and a 15-year technology and healthcare equity investor, she left the markets to build the company alongside her husband and co-founder, Anand Nathan. Since founding in 2019, AmplifyMD has grown to 300+ programs across 150+ clinical sites, a network of nearly 300 physicians, and 15+ specialties, raising $43M total including a $20M Series B in 2025 led by Forerunner Ventures.
Zag Bio
Zag Bio is a Cambridge, Massachusetts biotechnology startup pioneering thymus-targeted medicines for autoimmune disease. Founded and incubated by Polaris Partners and launched in October 2025 with an $80M Series A, the company designs bifunctional antibodies that ferry self-antigens directly into the thymus - the organ that trains immune cells - to re-teach the body to tolerate its own tissue rather than attack it. Its lead program, ZAG-101, aims to prevent or delay Type 1 diabetes by inducing durable, antigen-specific central tolerance instead of broad immunosuppression.
Acceleron Fusion, Inc.
Acceleron Fusion is a Cambridge, Massachusetts deep-tech company reviving muon-catalyzed fusion, a phenomenon first observed in the 1950s, as a path to abundant clean energy. Instead of confining a 100-million-degree plasma, Acceleron fires a beam of muons - subatomic particles roughly 200 times heavier than electrons - at highly compressed deuterium-tritium fuel, triggering fusion at temperatures closer to 500-1,000 C. Founded in 2023 by NK Labs veterans Ara Knaian and Seth Newburg and backed by a $24M Series A from Lowercarbon Capital and Collaborative Fund, the company is building two core technologies: a high-efficiency muon source and a high-density fusion cell, with the goal of a fusion power plant that beats natural gas on cost.
DARVIS
DARVIS is a health-tech company that uses AI-powered computer vision to give hospitals real-time visibility into their supply rooms. Its flagship product, Digital Shelves, uses smart PTZ cameras to continuously monitor inventory fill-levels and scan barcodes automatically, replacing manual counting with live consumption data, predictive demand planning, and automated reordering. Born in the gaming industry in 2015, the company pivoted to healthcare supply chain and now serves systems such as MD Anderson Cancer Center while operating from Cambridge, Massachusetts, with a hub in Hamburg, Germany, and a presence in Houston, Texas.